Literature DB >> 117485

Dopaminergic factors in human prolactin regulation: a pituitary model for the study of a neuroendocrine system in man.

G Langer, E J Sachar, R S Nathan, M A Tabrizi, J M Perel, F S Halpern.   

Abstract

This study in normal male subjects further investigates the effects of dopaminergic-antidopaminergic interactions as manifested by the prolactin response to dopamine and neuroleptic drugs. Incremental doses of dopamine hydrochloride (4 microgram/min, 15 microgram/min, 60 microgram/min, 300 microgram/min) were infused at a constant rate over 90-120 min after a fixed dose of a neuroleptic drug (sufficient for about half of the maximal prolactin response) had been given IV. A dose of dopamine in the order of 15-60 microgram/min appeared to match the "loss" of endogenous dopaminergic inhibition due to the antidopaminergic effect of the neuroleptic drug. The lactotrophic cells of the pituitary gland are suggested to serve as a model in man for the study of some basic neurohormonal mechanisms.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 117485     DOI: 10.1007/bf00433043

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

1.  Effect of haloperidol and L-dopa on plasma prolactin in stalk-sectioned and intact monkeys.

Authors:  G Langer; M Ferin; E J Sachar
Journal:  Endocrinology       Date:  1978-02       Impact factor: 4.736

2.  Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency.

Authors:  G Langer; E J Sachar; P H Gruen; F S Halpern
Journal:  Nature       Date:  1977-04-14       Impact factor: 49.962

3.  Drugs, neurotransmitters, and schizophrenia.

Authors:  S H Snyder; S P Banerjee; H I Yamamura; D Greenberg
Journal:  Science       Date:  1974-06-21       Impact factor: 47.728

4.  The prolactin response to neuroleptic drugs. A test of dopaminergic blockade: neuroendocrine studies in normal men.

Authors:  G Langer; E J Sachar; F S Halpern; P H Gruen; M Solomon
Journal:  J Clin Endocrinol Metab       Date:  1977-11       Impact factor: 5.958

5.  A homologous radioimmunoassay for human prolactin.

Authors:  Y N Sinha; F W Selby; U J Lewis; W P VanderLaan
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

6.  Effects of L-dopa on serum prolactin and PIF in intact and hypophysectomized, pituitary-grafted rats.

Authors:  K H Lu; J Meites
Journal:  Endocrinology       Date:  1972-10       Impact factor: 4.736

7.  Effect of dopamine and neuroleptics on plasma growth hormone and prolactin in normal men.

Authors:  G Langer; E J Sachar; F S Halpern
Journal:  Psychoneuroendocrinology       Date:  1978-04       Impact factor: 4.905

  7 in total
  2 in total

Review 1.  Neuroendocrine markers of CNS drug effects.

Authors:  E C Johnstone; I N Ferrier
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

Review 2.  Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Authors:  Chaya G Bhuvaneswar; Ross J Baldessarini; Veronica L Harsh; Jonathan E Alpert
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.